[144] Encompass Health Corporation SEC Filing

Rhea-AI Filing Summary

Encompass Health Corporation (EHC) Form 144 reports a proposed sale of 1,020 common shares via UBS Financial Services on the NYSE, with an aggregate market value of $126,061.80. The shares were acquired through restricted stock unit vesting in January–February 2023 (individual lots of 218, 290, 233 and 279 shares) and are scheduled for sale on 08/27/2025. The filer certifies no undisclosed material adverse information and provides no reportable sales in the prior three months.

Insights

Securities Analyst

TL;DR: Routine insider RSU sales planned; size (~$126k) is small relative to a large-cap issuer and likely immaterial to operations.

The filing documents a notice-of-intent to sell 1,020 shares acquired via RSU vesting in early 2023, executed through UBS on the NYSE. Because the aggregate value is modest, this appears to be a routine liquidity event rather than a signal of company-specific deterioration. The filer affirms no undisclosed material adverse information and reports no other sales in the prior three months.

Corporate Governance Specialist

TL;DR: Compliance disclosure consistent with Rule 144; timing and certification follow standard insider-sale protocols.

The Form 144 provides required details: acquisition method (RSU vesting), acquisition dates, planned sale date, broker, and market value. The signed representation that no material nonpublic information exists aligns with governance expectations when insiders sell. There is no indication of clustered or repeated large insider disposals in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	1020	126061.8	100723828	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2023	RSU Vesting	Encompass Health Corporation			218	08/27/2025	N/A
Common	01/02/2023	RSU Vesting	Encompass Health Corporation			290	08/27/2025	N/A
Common	02/24/2023	RSU Vesting	Encompass Health Corporation			233	08/27/2025	N/A
Common	02/25/2023	RSU Vesting	Encompass Health Corporation			279	08/27/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Encompass Health (EHC) Form 144 propose to sell?

The notice lists 1,020 common shares to be sold on the NYSE through UBS Financial Services.

When is the proposed sale date for the shares in the Form 144?

The approximate date of sale is listed as 08/27/2025.

How were the shares acquired that are being sold under Form 144?

All reported shares were acquired via RSU vesting in January–February 2023 (lots of 218, 290, 233, 279).

What is the aggregate market value of the shares to be sold?

The aggregate market value is listed as $126,061.80.

Does the filer report any other sales in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.